Many lung cancer cells express Met, with these cells and others in their microenvironment expressing their Met ligands [34], suggesting that these receptors and ligands modulate the sensitivity of cancer cells to molecular targeted drugs in their microenvironment. Here, MET is linked to lung cancer.